Histopathological evaluation in post-mortem renal biopsies of patients with COVID-19 and comorbidities: a case-control study
Keywords:
Biopsy, COVID-19, Diabetes mellitus, Essential hypertension, Acute kidney injury, SARS-CoV-2, Acute tubular necrosis, Diabetic nephropathy, Arterial hypertension, Histopathology, Acute renal failureAbstract
BACKGROUND: Acute kidney injury is one of the main systemic complications of severe coronavirus disease 2019 (COVID-19).
OBJECTIVES: To examine histopathological changes in post-mortem kidney biopsies of patients who died as a result of the disease caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
DESIGN AND SETTING: A case-control study was conducted at a tertiary hospital located in Curitiba, Paraná, Brazil.
METHODS: The study group, called “COVID,” consisted of kidney biopsy samples obtained from deceased patients with COVID-19, with a “Control” group included for comparison. Samples were selected based on sex, age, and comorbidities, with an emphasis on diabetes mellitus and systemic arterial hypertension (SAH). Morphological evaluation was performed by pathologists using preestablished criteria with glomerular, tubular, and vascular characteristics among the parameters.
RESULTS: Tubular atrophy and interstitial fibrosis, markers of chronic kidney injury, were observed with equal frequency in both groups, probably because of the initial pairing of the samples. These findings are in line with what would be expected from chronic exposure to proteinuria. In relation to SAH, the main identification was interstitial vascular damage, particularly arteriolosclerosis/arteriosclerosis. Acute tubular injury was the most frequently observed feature in patients in the COVID group, which was probably related to ischemic damage.
CONCLUSION: This study demonstrated that the main change identified in the renal parenchyma of patients with COVID-19 was acute tubular injury, which was expected considering the context of severe systemic ischemia to which these patients are subjected, with the other findings being the consequences of chronic damage.
Downloads
References
Coronavirus disease (COVID-19) situation reports [Internet]. World Health Organization (WHO). 2023 March [cited 2025 Oct 29]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
Bajema KL, Oster AM, McGovern OL, et al; 2019-nCoV Persons Under Investigation Team; 2019-CoV Persons Under Investigation Team. Persons evaluated for 2019 novel coronavirus: United States, January 2020. MMWR Morb Mortal Wkly Rep. 2020;69(6):166 70. PMID: 32053579; https://doi.org/10.15585/mmwr.mm6906e1.
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81. https://doi.org/10.1016/S2213-2600(20)30079-5. Erratum in: Lancet Respir Med. 2020;8(4):e26. PMID: 32105632; https://doi.org/10.1016/S2213-2600(20)30103-X.
Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. https://doi.org/10.1136/bmj.m1091. Erratum in: BMJ. 2020;368:m1295. PMID: 32217556; https://doi.org/10.1136/bmj.m1295.
Klok FA, Kruip MJHA, Van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7. PMID: 32291094; https://doi.org/10.1016/j.thromres.2020.04.013.
Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612–4. PMID: 32191259; https://doi.org/10.1001/jama.2020.4326.
Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients. Ann Clin Transl Neurol. 2020;7(11):2221–30. PMID: 33016619; https://doi.org/10.1002/acn3.51210.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5. Erratum in: Lancet. 2020;395(10223):496. PMID: 31986264; https://doi.org/10.1016/S0140-6736(20)30252-X.
Hirsch JS, Ng JH, Ross DW, et al; Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–18. PMID: 32416116; https://doi.org/10.1016/j.kint.2020.05.006.
Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38. PMID: 32247631; https://doi.org/10.1016/j.kint.2020.03.005.
Santoriello D, Khairallah P, Bomback AS, et al. Postmortem kidney pathology findings in patients with COVID-19. J Am Soc Nephrol. 2020;31(9):2158–67. PMID: 32727719; https://doi.org/10.1681/ASN.2020050744.
Nasr SH, Alexander MP, Cornell LD, et al. Kidney biopsy findings in patients with COVID-19, kidney injury, and proteinuria. Am J Kidney Dis. 2021;77(3):465–8. Epub 2020 Nov 18. PMID: 33217501; https://doi.org/10.1053/j.ajkd.2020.11.002.
Roufosse C, Simmonds N, Clahsen-van Groningen M, et al. A 2018 reference guide to the banff classification of renal allograft pathology. Transplantation. 2018;102(11):1795–814. https://doi.org/10.1097/TP.0000000000002366. Erratum in: Transplantation. 2018;102(12):e497. https://doi.org/10.1097/TP.0000000000002519. Erratum in: Transplantation. 2022;106(12):e528. PMID: 30028786; https://doi.org/10.1097/TP.0000000000004409.
Ertuğlu LA, Kanbay A, Afşar B, Elsürer Afşar R, Kanbay M. COVID-19 and acute kidney injury. Tuberk Toraks. 2020;68(4):407–18. PMID: 33448738; https://doi.org/10.5578/tt.70010.
Hilton J, Boyer N, Nadim MK, Forni LG, Kellum JA. COVID-19 and acute kidney injury. Crit Care Clin. 2022;38(3):473–89. PMID: 35667738; https://doi.org/10.1016/j.ccc.2022.01.002.
Ferlicot S, Jamme M, Gaillard F, et al; AP-HP/Universities/Inserm COVID-19 Research Collaboration. The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury, and/or proteinuria. Nephrol Dial Transplant. 2021:gfab042. PMID: 33576823; https://doi.org/10.1093/ndt/gfab042.
Rigo D, Orias M. Hypertension and kidney disease progression. Clin Nephrol. 2020 Supplement;93(1):103–7. PMID: 31549630; https://doi.org/10.5414/CNP92S118.
O’Connor AS, Schelling JR. Diabetes and the kidney. Am J Kidney Dis. 2005;46(4):766–73. PMID: 16183435; https://doi.org/10.1053/j.ajkd.2005.05.032.
Tervaert TW, Mooyaart AL, Amann K, et al; Renal Pathology Society. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556-63. PMID: 20167701; https://doi.org/10.1681/ASN.2010010010.
Pavkov ME, Collins AJ, Coresh J, Nelson RG. Kidney disease in diabetes. In: Cowie CC, Casagrande SS, Menke A, et al., editors. Diabetes in America [Internet]. 3rd ed. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 [cited 2025 Oct 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK568002/.
Najafian B, Crosson JT, Kim Y, Mauer M. Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol. 2006;17(4 Suppl 2):S53–S60. PMID: 16565248; https://doi.org/10.1681/ASN.2005121342.
Kopp JB. Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder. Curr Opin Nephrol Hypertens. 2013;22(3):266–72. PMID: 23470819; https://doi.org/10.1097/MNH.0b013e3283600f8c.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 São Paulo Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.